title: In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.
abstract: In the search for an effective anti-HIV microbicidal gel, limited drug penetration into the vaginal submucosa is a possible reason for failed protection against HIV transmission. To address this issue in early development, we here describe a simple in vitro strategy to predict the tissue permeation potential of vaginally applied drugs, based on solubility, permeability and flux assessment. We demonstrated this approach for four model microbicides (tenofovir, darunavir, saquinavir mesylate and dapivirine) and additionally examined the influence of formulation excipients on the permeation potential. When formulated in an aqueous-based HEC gel, high flux values across an HEC-1A cell layer were reached by tenofovir, as a result of its high aqueous solubility. In contrast, saquinavir and dapivirine fluxes remained low due to poor permeability and solubility, respectively. These low fluxes suggest limited in vivo tissue penetration, possibly leading to lack of efficacy. Dapivirine fluxes, however, could be enhanced up to 30-fold, by including formulation excipients such as polyethylene glycol 1000 (20%) or cyclodextrins (5%) in the HEC gels. Alternative formulations, i.e. emulsions or silicone elastomer gels, were less effective in flux enhancement compared to cyclodextrin-HEC gels. In conclusion, implementing the proposed solubility and permeability profiling in early microbicide development may contribute to the successful selection of promising microbicide candidates and appropriate formulations.
authors.affiliation: Laboratory for Pharmacotechnology and Biopharmacy, KU Leuven, Belgium.
authors.forename: Carolien
authors.initials: C
authors.lastname: Grammen
authors.forename: Patrick
authors.initials: P
authors.lastname: Augustijns
authors.forename: Joachim
authors.initials: J
authors.lastname: Brouwers
mesh_terms: D019380:Anti-HIV Agents / Q000737:chemistry / Q000493:pharmacokinetics*; D000890:Anti-Infective Agents / Q000737:chemistry / Q000493:pharmacokinetics*; D005079:Excipients / Q000737:chemistry*; D005260:Female; D006801:Humans; D008962:Models, Theoretical; D009092:Mucous Membrane / Q000187:drug effects*; D010539:Permeability; D012995:Solubility; D014621:Vagina / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D005079:Excipients